Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia
- PMID: 32988799
- PMCID: PMC7491483
- DOI: 10.1016/j.jacl.2020.09.002
Negative impact of COVID-19 pandemic on the lifestyle and management of patients with homozygous familial hypercholesterolemia
Comment in
-
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19.J Clin Lipidol. 2021 Mar-Apr;15(2):379-380. doi: 10.1016/j.jacl.2021.02.002. J Clin Lipidol. 2021. PMID: 34099192 Free PMC article. No abstract available.
References
-
- Kayikcioglu M., Tokgozoglu L., Yilmaz M. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry) Atherosclerosis. 2018;270:42–48. - PubMed
-
- Wang H., Yuan Z., Pavel M.A., Hansen S.B. The role of high cholesterol in age-related COVID19 lethality. bioRxiv. 2020 doi: 10.1101/2020.05.09.086249. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials